Bilayer Therapeutics

About:

Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon.

Website: https://bilayer-therapeutics.com/

Top Investors: Kendall Capital Partners

Description:

Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

tacollet(AT)alum.mit.edu

Founders:

Number of Employees:

1-10

Last Funding Date:

2021-04-28

IPO Status:

Private

Industries: